Survey: Change management crucial to EMR adoption

Jeff Byers | | Health Exec | Economics
Change management is as critical to EMR deployment success as IT planning and execution, according to a recent survey by Accenture.

The New York City-based technology and outsourcing company interviewed CIOs from select U.S. health systems from April to August of 2010. Key findings from the survey include:

  • Most major health systems underestimate the time and cost associated with implementing advanced EMR functions.
  • Hospitals can expect spikes in operating costs over the course of the EMR journey. Benchmarking shows that hospitals experience an 80 percent increase in IT operating expenses while transitioning to EMRs.
  • When it comes to healthcare IT resources to support EMR implementation, there is a significant gap in qualified personnel. Over the next year, it is estimated that 90 percent of hospitals will invest to install/upgrade EMRs, driving even greater competition for top IT talent.
  • True EMR success means working and thinking differently to optimize the investment over the long term.
Less than 1 percent of health systems achieved mature use of EMRs in 2009 and roughly 50 percent of U.S. hospitals are at risk of not meeting the demands of the federal requirements and incurring penalties by 2015, according to the company.

    Jeff Byers

    Related Content

    Merck spends up to $2B to license new weight loss drug with potential heart benefits
    Insulet wins $452M in lawsuit against rivals over medical device trade secrets
    Medical device company cuts 70% of staff in push to meet Medtronic obligations
    Cleerly’s momentum continues as AI specialists raise $106M
    Operations manager, doctors charged in $70M imaging kickback scheme
    Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

    Around the web

    Cardiovascular Business
    FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

    The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

    AI in Healthcare
    From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

    The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

    Cardiovascular Business
    Merck spends up to $2B to license new weight loss drug with potential heart benefits

    Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.